Greetings
about_greeting
Thank you for visiting CHEMAS.

CHEMAS is a pharmaceutical R&D company focusing on the development of cancer drugs. In particular, our research aims to discover and develop innovative medicines for cancer patients.

We have developed CM-7919 (As4O6), a drug which has shown beneficial results on several different cancer types in clinical trials. Other arsenic medicines such as Trisenox(As2O3) was approved by the FDA in 2000 as a treatment for acute promyelocytic leukemia (APL). As4S4 is known to be effective on chronic myeloid leukemia (CML) and was approved by the NMPA(National Medical Products Administration, China) in 2009.

As4O6 has a very stable molecular structure. Safety tests from GLP testing facility proved that CM-7919 has very little toxicity.

In Phase 1 clinical trial conducted in Asan Medical Center, we examined 15 patients with terminal cancer who had undergone unsuccessful surgical operations, chemotherapy, and radiotherapy treatments.
In 10 out of 15 patients treated with CM-7919, tumor either reduced in size or showed no further cancer progression. Particularly noteworthy is the very little side-effects from patients. Patients’ quality of life significantly improved as a result of using CM-7919. With the help of respected doctors and researchers in the field, we are continuing our research on the drug’s benefits and therapeutic potential.

In 2020, founder of CHEMAS and also the inventor of CM-7919, Ill Ju Bae, witnessed a worldwide pandemic and set off a project to test the substance on coronavirus infected cells. Results were highly promising as it has 100% inhibited virus proliferation from 1% concentration until 2000 fold diluted concentration. We are now planning Phase II clinical trials for COVID-19 in Europe.

We believe in the value of collaboration, particularly if it helps us achieve our goal of developing breakthrough treatments for patients suffering from cancer and other viral diseases. We are eager to develop partnership with professionals and global pharmaceuticals and glad to welcome the opportunity to discuss such collaboration.

In addition, we place high value on being a responsible business entity; we will never stop our dedication on developing treatments which could improve the lives of those suffering from cancer and other diseases. We are passionate about having a positive, healthy impact on patients and societies in general and our goal is to ultimately bring about positive changes across the world.

Search